International UK medical pot patients see positive changes and few adverse effects Patients' health-related quality of life typically improves across a broad spectrum of chronic conditions Kathryn TindaleJanuary 27, 2022
Legalization South Dakota lawmakers look to repeal home cultivation of medical pot Despite South Dakotans voting for cannabis reform in 2020, their governor and lawmakers have challenged the resulting laws Kathryn TindaleJanuary 26, 2022
Business Beloved medical cannabis seller Shelter Market shutters operations It appears the company will continue operations through its Agro Greens business in Saskatchewan Nick LabaJanuary 25, 2022
Medical and Pharmaceutical New York allows medical pot for any condition at doctors’ discretion Most states only allow doctors to prescribe pot based on a list of qualifying conditions Kathryn TindaleJanuary 25, 2022
International Costa Rica’s president to propose alternative medical cannabis bill Lawmakers and industry groups have called on the president to not veto the currently proposed bill Kathryn TindaleJanuary 24, 2022
COVID-19 Clinical trial in UK to look at medical cannabis as treatment for long Covid About 1.3M people in the UK have long Covid Kathryn TindaleJanuary 17, 2022
Canada ATMA to run clinical trial for synthetic psilocybin on medical professionals Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects Natalia Buendia CalvilloJanuary 11, 2022
Canada What amendments to Canada’s restricted drug program mean for patients and practitioners The new rules will facilitate safer access to substances like psilocybin, but many in need won't qualify, experts say Natalia Buendia CalvilloJanuary 11, 2022
International Czech Republic eases rules for cannabis patients Recent regulatory amendments signal greater acceptance of cannabis as medicine in the country Nick LabaJanuary 6, 2022
International France bans sale of CBD flower and leaves under new regulations Industry organizations say they've taken action against the new regulations Kathryn TindaleJanuary 4, 2022